NCT06449404 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
| NCT ID | NCT06449404 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | Parkinson's Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-03-01 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
Eligibility Criteria
Inclusion Criteria: * the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders Exclusion Criteria: * the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease; * psychiatric disorders with impaired cognitive function; * contraindications to MRI.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06449404 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Parkinson's Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06449404 currently recruiting?
Yes, NCT06449404 is actively recruiting participants. Contact the research team at plaluhaoxaun@163.com for enrollment information.
Where is the NCT06449404 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06449404 clinical trial?
NCT06449404 is sponsored by Chinese PLA General Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.